2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
生物活性
Description
In Vivo
In Vitro
化合物的使用
Kinase Assay
Cell Assay
Animal Administration
参考文献
BPR1J-097 is a novel small molecule FLT-3 inhibitor(IC50=11±7 nM) with promising in vivo anti-tumour activities; inhibits FLT-3 D835Y with an IC50 of 3 nM.
For the detailed information of BPR1J-097, the solubility of BPR1J-097 in water, the solubility of BPR1J-097 in DMSO, the solubility of BPR1J-097 in PBS buffer, the animal experiment (test) of BPR1J-097, the cell expriment (test) of BPR1J-097, the in vivo, in vitro and clinical trial test of BPR1J-097, the EC50, IC50,and affinity,of BPR1J-097, For the detailed information of BPR1J-097, the solubility of BPR1J-097 in water, the solubility of BPR1J-097 in DMSO, the solubility of BPR1J-097 in PBS buffer, the animal experiment (test) of BPR1J-097, the cell expriment (test) of BPR1J-097, the in vivo, in vitro and clinical trial test of BPR1J-097, the EC50, IC50,and affinity,of BPR1J-097, Please contact DC Chemicals.
